Oliver Brain

3.6k total citations · 2 hit papers
45 papers, 2.0k citations indexed

About

Oliver Brain is a scholar working on Genetics, Epidemiology and Oncology. According to data from OpenAlex, Oliver Brain has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 18 papers in Epidemiology and 17 papers in Oncology. Recurrent topics in Oliver Brain's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (16 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Oliver Brain is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (16 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Oliver Brain collaborates with scholars based in United Kingdom, Australia and United States. Oliver Brain's co-authors include Alison Simmons, Philip Allan, Derek P. Jewell, Tica Pichulik, Rachel Cooney, Bénédicte Danis, David Ferguson, Barry J. Campbell, Simon Travis and Robert V. Bryant and has published in prestigious journals such as Nature Medicine, Immunity and Gastroenterology.

In The Last Decade

Oliver Brain

41 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation

2009 819 citations Rachel Cooney, Oliver Brain et al. Nature Medicine profile →
Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up

2015 300 citations Robert V. Bryant, Daniel Burger et al. Gut profile →

Peers

Countries citing papers authored by Oliver Brain

Since Specialization

Citations

This map shows the geographic impact of Oliver Brain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Brain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Brain more than expected).

Fields of papers citing papers by Oliver Brain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Brain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Brain. The network helps show where Oliver Brain may publish in the future.

Co-authorship network of co-authors of Oliver Brain

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Brain. A scholar is included among the top collaborators of Oliver Brain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Brain. Oliver Brain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	OP06 HLA-DQA105:01 is associated with loss of response to infliximab, and HLA DQA105:05 with loss of response to adalimumab in the Oxford OASIS study 2025 ·Journal of Crohn s and Colitis ·(unknown), (unknown), Elaine Neary, Belén Pérez, Nicole Bedke, Oliver Brain, Jack Satsangi, Nicola Ternette, (unknown)	0
2	Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response 2022 ·Gut ·Alex Adams, Vipin Gupta, (unknown), Thomas Chapman, (unknown), (unknown), (unknown), Saurabh Kedia, (unknown), Tim Ambrose, Bruce George, Rebecca Palmer, Oliver Brain, Alissa Walsh, Vineet Ahuja, Simon Travis, Jack Satsangi	47
3	Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles 2021 ·British Journal of Cancer ·Weiyu Ye, Anna Olsson‐Brown, Robert Watson, Vincent Cheung, Robert D. Morgan, Isar Nassiri, Rosalin Cooper, Chelsea Taylor, (unknown), Oliver Brain, Rubeta Matin, Nicholas Coupe, Mark R. Middleton, Mark Coles, Joseph J. Sacco, Miranda Payne, Benjamin P. Fairfax	33
4	P93 Faecal microbiota transplant for refractory checkpoint inhibitor immunotherapy-related colitis 2021 ·Vincent Cheung, Sarah C. Sasson, Mariya Misheva, (unknown), Tarun Gupta, Gwilym J. Webb, Alissa Walsh, Alison Simmons, (unknown), Tariq Iqbal, Mark R. Middleton, Benjamin P. Fairfax, Miranda Payne, James McCullagh, Paul Klenerman, Oliver Brain	2
5	P127 Real world effectiveness of ustekinumab for refractory Crohn’s disease: a regional experience 2021 ·(unknown), (unknown), (unknown), Cameron Griffiths, Thomas Chapman, Alex Adams, Darren Wong, (unknown), Oliver Brain, Timothy Ambrose, Rebecca Palmer, Aminda De Silva, Alissa Walsh, Simon Travis, Jack Satsangi	1
6	Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma 2021 ·Scientific Reports ·Sarah C. Sasson, Laura Wilkins, (unknown), (unknown), Oliver Brain, Paul Klenerman, Anna Olsson‐Brown, Benjamin P. Fairfax	6
7	P241 Early prediction of outcome in acute severe ulcerative colitis (ASC): comparison of clinical and endoscopic indices at presentation, with day 3 criteria 2020 ·Journal of Crohn s and Colitis ·Gupta, (unknown), Alex Adams, Aisling Murphy, Dharshan Sathananthan, (unknown), Oliver Brain, Rebecca Palmer, Tim Ambrose, Bruce George, Alissa Walsh, Simon Travis, Jack Satsangi	0
8	Immunotherapy induced enterocolitis and gastritis – What to do and when? 2020 ·Best Practice & Research Clinical Gastroenterology ·Vincent Cheung, Oliver Brain	12
9	Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way? 2020 ·British Journal of Cancer ·Vincent Cheung, Tarun Gupta, Anna Olsson‐Brown, Sreedhar Subramanian, Sarah C. Sasson, (unknown), Eve Fryer, Elena Collantes, Joseph J. Sacco, Munir Pirmohamed, Alison Simmons, Paul Klenerman, Mark Tuthill, Andrew Protheroe, Meenali Chitnis, Benjamin P. Fairfax, Miranda Payne, Mark R. Middleton, Oliver Brain	57
10	PTU-061 Immunotherapy-related gastritis in a tertiary oncology centre 2019 ·Vincent Cheung, Tarun Gupta, Weiyu Ye, Mark R. Middleton, (unknown), Miranda Payne, Oliver Brain	6
11	P100 Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres 2019 ·Journal of Crohn s and Colitis ·Vincent Cheung, Tejpal Gupta, Anna Olsson‐Brown, Sreedhar Subramanian, Miranda Payne, Mark R. Middleton, Oliver Brain	2
12	Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis 2019 ·Intestinal Research ·Alissa Walsh, (unknown), Christopher Hinds, (unknown), Oliver Brain, Satish Keshav, John Geddes, Guy M. Goodwin, Gary S. Collins, Simon Travis, Michele Peters	13
13	Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis 2016 ·Journal of Crohn s and Colitis ·(unknown), Emily Wendt, Lai Mun Wang, Alissa Walsh, Daniel Burger, Robert V. Bryant, (unknown), (unknown), Oliver Brain, Simon Travis, Satish Keshav	14
14	Conventional drug therapy for inflammatory bowel disease 2014 ·Scandinavian Journal of Gastroenterology ·Robert V. Bryant, Oliver Brain, Simon Travis	63
15	The Intracellular Sensor NOD2 Induces MicroRNA-29 Expression in Human Dendritic Cells to Limit IL-23 Release 2013 ·Immunity ·Oliver Brain, Benjamin M. J. Owens, Tica Pichulik, Philip Allan, Elham Khatamzas, Alasdair Leslie, Tessa A. M. Steevels, Sameer Sharma, Alice Mayer, Ana Catuneanu, Victoria Hodgetts Morton, Meiyi Sun, Derek P. Jewell, Margherita Coccia, Oliver J. Harrison, Kevin J. Maloy, Susann Schönefeldt, Simon Bornschein, Adrian Liston, Alison Simmons	155
16	NOD2 regulation of micrornas 2011 ·Gut ·Oliver Brain, Philip Allan, Tica Pichulik, Elham Khatamzas, Peter Simpson, D P Jewell, Alison Simmons	4
17	HOW MUCH AGREEMENT IS THERE BETWEEN HISTOLOGICAL, ENDOSCOPIC AND CLINICAL ASSESSMENTS OF REMISSION IN ULCERATIVE COLITIS? 2009 ·Oxford University Research Archive (ORA) (University of Oxford) ·(unknown), A Walsh, A. von Herbay, (unknown), Oliver Brain, Satish Keshav, Bryan F. Warren, Simon Travis	9
18	NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation breakdown → 2009 ·Nature Medicine ·Rachel Cooney, (unknown), Oliver Brain, Bénédicte Danis, Tica Pichulik, Philip Allan, David Ferguson, Barry J. Campbell, Derek P. Jewell, Alison Simmons	819
19	Markedly elevated CA19-9 associated with benign ovarian cyst and ascites 2009 ·BMJ Case Reports ·Oliver Brain, (unknown), (unknown), Rachel Chapman	7
20	Therapy of ulcerative colitis: state of the art 2008 ·Current Opinion in Gastroenterology ·Oliver Brain, Simon Travis	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact